Powder for Oral Solution
PEG 3350, Sodium Ascorbate, Sodium Sulfate, Ascorbic Acid, Sodium Chloride, and Potassium Chloride
To help us tailor the content and information specifically to you, please confirm your identity below.
If you get any side effects, talk to your doctor, nurse or pharmacist. Adverse events should be reported to your regulatory agency. Adverse events should also be reported directly to Norgine Ltd by emailing GPharmacoVigilance@norgine.com. By reporting side effects you can help provide more information on the safety of this medicine.
Registered number 30127007. Copyright Norgine 2019.
Norgine B.V., Antonio Vivaldistraat 150, 1083 HP Amsterdam. The Netherlands.
PLENVU, MOVIPREP, NORGINE and the sail logo are registered trademarks of the Norgine group of companies.
Images of people are for illustrative purposes only. Any persons depicted are models and do not use or personally endorse PLENVU®.
You are currently on the PLENVU® Global website.
Please confirm which site you would like to proceed with below:
GL/PLV/0518/0066a
